Literature DB >> 9554902

Adverse drug reactions.

M Pirmohamed1, A M Breckenridge, N R Kitteringham, B K Park.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9554902      PMCID： PMC1113033          DOI： 10.1136/bmj.316.7140.1295

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  36 in total

Review 1.  Drug disposition and drug hypersensitivity.

Authors:  B K Park; J W Coleman; N R Kitteringham
Journal:  Biochem Pharmacol       Date:  1987-03-01       Impact factor: 5.858

2.  Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.

Authors:  C C Smith; P M Bennett; H M Pearce; P I Harrison; D J Reynolds; J K Aronson; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1996-10       Impact factor: 4.335

3.  Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency.

Authors:  M Pirmohamed; D Williams; M D Tingle; M Barry; S H Khoo; C O'Mahony; E G Wilkins; A M Breckenridge; B K Park
Journal:  AIDS       Date:  1996-05       Impact factor: 4.177

Review 4.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

5.  Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts.

Authors:  W Lewis; E S Levine; B Griniuviene; K O Tankersley; J M Colacino; J P Sommadossi; K A Watanabe; F W Perrino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 6.  Medication-related adverse reactions and the elderly: a literature review.

Authors:  P A Atkin; G M Shenfield
Journal:  Adverse Drug React Toxicol Rev       Date:  1995

Review 7.  The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Pharmacol Ther       Date:  1995       Impact factor: 12.310

8.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D C Classen; S L Pestotnik; R S Evans; J F Lloyd; J P Burke
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

9.  The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.

Authors:  D W Bates; N Spell; D J Cullen; E Burdick; N Laird; L A Petersen; S D Small; B J Sweitzer; L L Leape
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

10.  Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.

Authors:  R R Shah; N S Oates; J R Idle; R L Smith; J D Lockhart
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30
View more
  101 in total

1.  Underreporting of adverse drug reactions: attitudes of Irish doctors.

Authors:  D Williams; J Feely
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

2.  A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.

Authors:  D Sweis; I C Wong
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

Review 3.  Methods and systems to detect adverse drug reactions in hospitals.

Authors:  P A Thürmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  New insights into drug metabolism and toxicology report of a symposium on drug metabolism and toxicity held at the British Pharmacological Society Meeting in Cardiff, UK, in July 2000.

Authors:  M A Shaw
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

5.  Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting.

Authors:  C F Green; D R Mottram; P H Rowe; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

6.  The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

Authors:  R M Martin; N R Dunn; S Freemantle; S Shakir
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

Review 7.  Adverse drug reactions: back to the future.

Authors:  Munir Pirmohamed; B Kevin Park
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

Review 8.  Application of data mining techniques in pharmacovigilance.

Authors:  Andrew M Wilson; Lehana Thabane; Anne Holbrook
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

9.  Adverse drug reactions in internal medicine units and associated risk factors.

Authors:  Juan Francisco Sánchez Muñoz-Torrero; Paloma Barquilla; Raul Velasco; Maria del Carmen Fernández Capitan; Nazaret Pacheco; Lucia Vicente; Jose Luis Chicón; Sara Trejo; Jose Zamorano; Alicia Lorenzo Hernandez
Journal:  Eur J Clin Pharmacol       Date:  2010-08-06       Impact factor: 2.953

10.  Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009.

Authors:  Tai-Yin Wu; Min-Hua Jen; Alex Bottle; Mariam Molokhia; Paul Aylin; Derek Bell; Azeem Majeed
Journal:  J R Soc Med       Date:  2010-06       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.